{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:02:57Z","timestamp":1778220177127,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.anai.2016.06.017","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T02:33:33Z","timestamp":1481510013000},"page":"589-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhaled corticosteroids"],"prefix":"10.1016","volume":"117","author":[{"given":"Warner W.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley J.","family":"Szefler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 suppl","key":"10.1016\/j.anai.2016.06.017_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0091-6749(03)01859-1","article-title":"Inhaled corticosteroids: past lessons and future issues","volume":"112","author":"Allen","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib2","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, updated 2016. http:\/\/ginasthma.org\/2016-gina-report-global-strategy-for-asthma-management-and-prevention\/. Accessed December 17, 2015."},{"key":"10.1016\/j.anai.2016.06.017_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaip.2015.05.005","article-title":"Progression of irreversible airflow limitation in asthma: correlation with severe exacerbations","volume":"3","author":"Matsunaga","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2016.06.017_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2005.10.012","article-title":"Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma","volume":"117","author":"Zeiger","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.201210-1853PP","article-title":"Inhaled corticosteroids in lung diseases","volume":"187","author":"Raissy","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2016.06.017_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.anai.2016.06.017_bib9","first-page":"469","article-title":"Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease","volume":"9","author":"Tripathi","year":"1992","journal-title":"Lens Eye Toxic Res"},{"key":"10.1016\/j.anai.2016.06.017_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1081-1206(10)62545-8","article-title":"Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients","volume":"85","author":"Duh","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40266-012-0029-9","article-title":"Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study","volume":"29","author":"Marcus","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.anai.2016.06.017_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/0974-9233.97936","article-title":"Effects of inhaled fluticasone on intraocular pressure and central corneal thickness in asthmatic children without a family history of glaucoma","volume":"19","author":"Alsaadi","year":"2012","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.anai.2016.06.017_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5301\/ejo.5000141","article-title":"Short-term use of inhaled and intranasal corticosteroids is not associated with glaucoma progression on optical coherence tomography","volume":"22","author":"Johnson","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.anai.2016.06.017_bib14","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/S0161-6420(99)90530-4","article-title":"Inhaled corticosteroids, family history, and risk of glaucoma","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.anai.2016.06.017_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-6749(93)90263-F","article-title":"Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma","volume":"91","author":"Toogood","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(93)91541-S","article-title":"Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids","volume":"342","author":"Simons","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2016.06.017_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/thx.50.6.674","article-title":"Posterior subcapsular cataract and inhaled corticosteroid therapy","volume":"50","author":"Abuekteish","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2016.06.017_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.280.6.539","article-title":"Association of inhaled corticosteroid use with cataract extraction in elderly patients","volume":"280","author":"Garbe","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2016.06.017_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","article-title":"Use of inhaled corticosteroids and the risk of cataracts","volume":"337","author":"Cumming","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 49","key":"10.1016\/j.anai.2016.06.017_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1398-9995.1999.tb04385.x","article-title":"Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids","volume":"54","author":"Allen","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2016.06.017_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2016.06.017_bib22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.118.6.1538","article-title":"Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses","volume":"118","author":"Affrime","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.anai.2016.06.017_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.anai.2012.08.017","article-title":"Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids","volume":"109","author":"Bleecker","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2500\/aap.2016.37.3912","article-title":"Adrenal suppression by inhaled corticosteroids in patients with asthma: a systematic review and quantitative analysis","volume":"37","author":"Kowalski","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.06.017_bib25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.rmed.2011.07.017","article-title":"Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy","volume":"105","author":"Brand","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2016.06.017_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/14750708.2.2.167","article-title":"Ciclesonide: a novel inhaled corticosteroid for the treatment of persistent asthma: a pharmacologic and clinical profile","volume":"2","author":"Berger","year":"2005","journal-title":"Therapy"},{"key":"10.1016\/j.anai.2016.06.017_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ppul.20474","article-title":"A\u00a0comparative study of inhaled ciclesonide 160 microg\/day and fluticasone propionate 176 microg\/day in children with asthma","volume":"41","author":"Pedersen","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anai.2016.06.017_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3038.2007.00538.x","article-title":"Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma","volume":"18","author":"von Berg","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2016.06.017_bib29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.rmed.2010.06.012","article-title":"Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study","volume":"104","author":"Pedersen","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2016.06.017_bib30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2006-2206","article-title":"Ciclesonide Pediatric Growth Study G. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma","volume":"121","author":"Skoner","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2016.06.017_bib31","series-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","author":"National Asthma Education and Prevention Program","year":"2007"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616303611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616303611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:15:52Z","timestamp":1761052552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616303611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1081120616303611"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.06.017","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}